Bells and Whistles. ACI-35.030 includes a phospho-tau peptide anchored to a liposomal bilayer, along with two adjuvants and a non-target T cell epitope to rally B cells to churn out antibodies against phospho-tau. [Courtesy of Johannes Streffer, AC Immune]
The work of our faculty, researchers, and collaborators was highlighted in a recent Alzforum article on anti-tau vaccines.
- AC Immune updates Phase 1b/2 comparison of two anti-#tau vaccines.
- A liposomal vaccine prompted #antibody response against phospho-tau.
- Preclinical data bode well for another tau vaccine; first trial slated for next year.
